The key technology of the biomolecule copier was developed at the Albert-Ludwigs-University Freiburg / Germany by the company founders Dr. Günter Roth and Dr. Jürgen Burger.
The University of Freiburg has a portfolio of seven patent applications with a term extending beyond 2030. In each patent family, patents have already been granted in the most important markets. There are agreements as to how the respective patents will be transferred to BioCopy in the course of the commencement of business. The portfolio covers the basic technology, devices, copy modes, as well as another 40 applications of biomolecule copy technology.